Latest Regulatory Clearance News

Sprintex boosted its commercial footprint in the June quarter with a 65% order book increase from Mest Water, a paid trial at Taiwan's TSMC, and Dutch regulatory clearance lifting key uncertainties.

RooLife Group (ASX:RLG) is expanding its renewable energy footprint by acquiring a battery storage and microgrid business and raising $1.06 million in a placement to fund growth and project delivery.

PainChek lifted implemented ARR by 5.9% to $4.46 million and secured its first US commercial contracts under a major Sabra REIT agreement, boosting customer receipts 27% in the June quarter.

ReNerve Limited delivered its strongest sales quarter ever with $211,000 in revenue, boosted by new distribution deals in Asia-Pacific and a $5 million funding facility to underpin growth.

Australian Strategic Materials (ASM) has announced a revised timetable for its shareholder scheme meetings tied to Energy Fuels’ acquisition, alongside dispatching a supplementary booklet that updates key transaction details including a new expert report. The acquisition now contemplates Energy Fuels’ conditional US$725 million financing and a US$1.9 billion deal to acquire VAC.

Lumos Diagnostics reported a 6% revenue increase to US$13.2 million for FY26, driven by an 875% surge in FebriDx® sales following a pivotal CLIA waiver. The company expanded U.S. adoption to 170+ healthcare sites and secured milestone payments exceeding US$6 million.

Lake Resources has raised A$3.8 million through an at-the-market placement priced above recent trading levels, earmarked for environmental and power optimisation work at its Kachi lithium project.

BlinkLab has bolstered its war chest with a A$17.5 million placement, secured a foundational US patent valid through 2041, and made significant progress in its FDA autism diagnostic trial and European ADHD study.

Evolution Mining has agreed to acquire Carnaby Resources via a scheme of arrangement valuing Carnaby at around A$213 million, delivering a 60% premium to shareholders and aiming to de-risk the Greater Duchess project.

ClearView Wealth’s board has approved a fully franked $0.05 special dividend, contingent on the successful completion of Zurich’s $415 million acquisition scheme. The dividend reduces the takeover price but, with franking credits, could enhance total shareholder value.

Harvest Technology Group has inked a non-binding partnership with Ukrainian Technopark to explore integrating its ultra-low-bandwidth Nodestream platform into unmanned defence systems, focusing on resilient communications under electronic warfare conditions.

PYC Therapeutics has secured Safety Review Committee approval to escalate dosing in its Phase 1b trial of PYC-003 for Polycystic Kidney Disease, alongside regulatory clearance for an Open-Label Extension allowing continuous dosing up to 24 months.